Gene expression profile of renal cell carcinoma clear cell type

Abstract

Purpose: The determination of prognosis in patients with renal cell carcinoma (RCC) is based, classically, on stage and histopathological aspects. The metastatic disease develops in one third of patients after surgery, even in localized tumors. There are few options for treating those patients, and even the new target designed drugs have shown low rates of success in controlling disease progression. Few studies used high throughput genomic analysis in renal cell carcinoma for determination of prognosis. This study is focused on the identification of gene expression signatures in tissues of low-risk, high-risk and metastatic RCC clear cell type (RCC-CCT). Materials and Methods:We analyzed the expression of approximately 55,000 distinct transcripts using the Whole Genome microarray platform hybridized with RNA extracted from 19 patients submitted to surgery to treat RCC-CCT with different clinical outcomes. They were divided into three groups (1) low risk, characterized by pT1, Fuhrman grade 1 or 2, no microvascular invasion RCC; (2) high risk, pT2-3, Fuhrman grade 3 or 4 with, necrosis and microvascular invasion present and (3) metastatic RCC-CCT. Normal renal tissue was used as control. Results: After comparison of differentially expressed genes among low-risk, high-risk and metastatic groups, we identified a group of common genes characterizing metastatic disease. Among them Interleukin-8 and Heat shock protein 70 were over-expressed in metastasis and validated by real-time polymerase chain reaction. Conclusion: These findings can be used as a starting point to generate molecular markers of RCC-CCT as well as a target for the development of innovative therapies.

Regulation of CXCL8/IL-8 Expression by Zonula Occludens-1 in Human Breast Cancer Cells

“…Freund and colleagues have also reported that CXCL8/IL-8 mRNA expression is 80-fold higher in MDA-MB-231 than in MCF7 cells (39). Furthermore, our data are in agreement with studies reporting CXCL8/IL-8 expression in a variety of human cancer cell lines, including renal carcinoma cells (40), melanoma cells (26,41,42), breast cancer cells (43), prostate cancer cells (44), colon carcinoma cells (45), and bladder cancer cells (46). Also, these studies associated CXCL8/IL-8 expression and the metastatic potential of the cancer cells.…”

LncRNAs Expression Signatures of Renal Clear Cell Carcinoma Revealed by Microarray

“…RCCC is a genetic disease like other cancers which are caused by a series of genetic alterations [5] . Description of thousands of genomic sequences along with the technological development to identify the gene expression profiles on a large scale has provided a remarkable improvement in the analysis of carcinogenesis [25] . The improved technology may help us finding of possible therapeutic targets and identification of new diagnostic and prognostic markers.…”

Aberrant expression of long noncoding RNAs in chronic thromboembolic pulmonary hypertension

“…CTEPH is a polygenic disorder, resulting from genetic alterations. The description of thousands of genomic sequences, along with technological developments enabling the identification of gene expression profiles on a large scale, have improved the understanding of the pathogenesis of a number of diseases, including cancer ( 34 ). These advances may also facilitate the development of novel therapeutic targets, as well as diagnostic and prognostic markers.…”